[ Main Page | Editorial Board | About | Instructions ]
[ Table of Contents | Archive | Archive Search | Online Submission | E-mail ]

Turkish Journal of Cancer
2006, Volume 36, Number 1
17 article(s) found.
  • Acute arterial thrombosis related to 5-fluorouracil and cisplatin combination chemotherapy regimen in an elderly patient
         HÜSEYİN ENGİN, HÜSEYİN ABALI, SERCAN AKSOY, İSMAİL ÇELİK
  • 99mTc-MAG3/Renal Scintigraphy and Functional Parameters for the Evaluation of Cisplatin Nephrotoxicity
         BELKIS ERBAŞ, HALUK ÖZEN, MURAT LEKİLİ, GÜNAYDIN ERBENGİ, COŞKUN BEKDİK
  • Cisplatin and five-day continuous infusion of 5-fluorouracil in patients with recurrent and disseminated cancer of the head and neck
         İBRAHİM GÜLLÜ, GÜLTEN TEKUZMAN, EŞMEN BALTALI, AYŞE KARS, İBRAHİM BARIŞTA, NİLÜFER GÜLER, ÖZGÜR ÖZYILKAN, YAVUZ ÖZlŞIK, DİNÇER FIRAT
  • High frequency audiometry and auditory brain stem response in ototoxicity of cisplatinum
         SEMHA BERBEROĞLU1, BİLGEHAN BÖKE2, MÜNEVVER BÜYÜKPAMUKÇU1, FAİK SARIALİOĞLU1, CANAN AKYÜZ1, EROL BELGİN2
  • Prevention of chemotherapy-induced emesis in patients with germ cell tumors receiving multiple-day cisplatin-based chemotherapy: efficacy and tolerability of tropisetron
         HALUK ONAT, SEVİL E. İNANÇ, PINAR SAİP, ERKAN TOPUZ
  • Phase II study of combination of carboplatin and chronic oral etoposide in pre-treated metastatic breast cancer
         ADNAN EZZAT, SHOUKI BAZARBASHI, AMER RADWI, AHMED EL-WARITH, MADRAS RAJA, MOHAMED RAHAL, JOAN BELENO
  • Cardiotoxicity of 5-fluorouracil: Two cases with severe bradycardia and review of the literature
         MUSTAFA SAMUR1, ALİ ARICAN1, MEHTAP ÇAKIR2, ORHAN ŞENCAN1, AHMET DEMİRKAZIK1, HAKAN AKBULUT1, FİKRİ İÇLİ1
  • Docetaxel (Taxotere) in the salvage treatment of anthracycline resistant metastatic breast cancer
         NİLÜFER GÜLER, EŞMEN BALTALI, KADRİ ALTUNDAĞ, NURULLAH ZENGİN, YAVUZ ÖZIŞIK, GÜLTEN TEKUZMAN, DİNÇER FIRAT
  • Gemcitabine and cisplatin in the treatment of patients with locally advanced and metastatic pancreatic carcinoma
         MUSTAFA ALTINBAŞ1, METİN ÖZKAN1, ÖZLEM ER1, HASAN ŞENOL COŞKUN1, BÜNYAMİN KAPLAN2, CAN KÜÇÜK3, FEVZİ ALTUNTAŞ1, BÜLENT ESER1
  • Bioassay for determination of cisplatin activity in serum and urine
         SHAHBAL B. KANGARLOO1, SUMAN B. GANGOPADHYAY1, STEFAN GLÜCK1, JOHANNES E.A. WOLFF1,2
  • The efficacy of preoperative cisplatin and 5-fluorouracil combination in patients with stage III squamous cell carcinoma of the esophagus
         SERDAR HAN1, BÜLENT YALÇIN2, HAKAN AKBULUT2, İLKER ÖKTEN3
  • Treatment approaches for metastatic breast cancer in Turkey
         
  • 5-Fluorouracil, epirubicin and cisplatin (FEP) in the treatment of metastatic gastric carcinoma
         ÖZKAN KANAT1, TÜRKKAN EVRENSEL1, ENDER KURT1, MUTLU DEMİRAY1, MURAT ARSLAN1, GÜZİN GÖNÜLLÜ1, NALAN BABACAN2, ABDÜLMECİT YILDIZ2, OSMAN MANAVOĞLU1
  • Phase II study of gemcitabine plus epirubicin plus paclitaxel in metastatic breast cancer patients
         MUTLU DEMİRAY1, TÜRKKAN EVRENSEL1, MURAT ARSLAN1, ÖZKAN KANAT1, ENDER KURT1, ÖZLEM SARAYDAROĞLU2, İLKER ERCAN3, ŞEHSUVAR GÖKGÖZ4, UĞUR TOPAL5, ŞAHSİNE TOLUNAY2, İSMET TAŞDELEN4, OSMAN MANAVOĞLU1
  • The effect of EGFR overexpression in inoperable non-small cell lung cancer (NSCLC) patients receiving cisplatinvinorelbine combination
         MAHMOUD A. SALAM1, TAMER ELNAHHAS1, HATEM A. AZIM2, SAMY ALSIRAFY1
  • Single-agent vinorelbine as third-line chemotherapy for refractory non-small cell lung cancer
         ÖZKAN KANAT1, FATİH ÖLMEZ2, ENDER KURT1, ABDÜLMECİT YILDIZ2, TÜRKKAN EVRENSEL1, ELVAN KANAT3, OSMAN MANAVOĞLU1
  • The prevalence of silent arrhythmia in patients receiving cisplatin-based chemotherapy
         ÖZLEM YAVAŞ1, KUDRET AYTEMİR2, İSMAİL ÇELİK1
  •  

    [ Main Page | Editorial Board | About | Instructions ]
    [ Table of Contents | Archive | Archive Search | Online Submission | E-mail ]